| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 148.551 | 689.257 | 930.954 | 1.281.798 | 2.972.771 | 3.617.674 |
| Total Income - EUR | - | - | - | - | 148.551 | 690.131 | 965.837 | 1.305.851 | 2.972.805 | 3.617.750 |
| Total Expenses - EUR | - | - | - | - | 107.259 | 571.937 | 903.673 | 1.069.531 | 2.164.279 | 2.851.405 |
| Gross Profit/Loss - EUR | - | - | - | - | 41.292 | 118.194 | 62.164 | 236.320 | 808.526 | 766.345 |
| Net Profit/Loss - EUR | - | - | - | - | 39.806 | 111.423 | 53.665 | 228.827 | 680.344 | 657.795 |
| Employees | - | - | - | - | 5 | 5 | 9 | 11 | 15 | 25 |
Check the financial reports for the company - Dumsil Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 39.370 | 140.890 | 747.673 | 913.288 | 847.768 | 1.033.155 |
| Current Assets | - | - | - | - | 79.228 | 545.094 | 617.675 | 1.174.763 | 1.576.119 | 2.093.783 |
| Inventories | - | - | - | - | 0 | 144.696 | 96.365 | 90.820 | 1.945 | 4.363 |
| Receivables | - | - | - | - | 59.462 | 261.249 | 502.372 | 723.252 | 1.498.100 | 1.858.585 |
| Cash | - | - | - | - | 19.765 | 139.149 | 18.938 | 360.690 | 76.074 | 230.834 |
| Shareholders Funds | - | - | - | - | 39.848 | 150.516 | 169.004 | 398.356 | 681.824 | 1.325.204 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 78.749 | 535.469 | 1.196.344 | 1.689.695 | 1.653.858 | 1.714.022 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4100 - 4100" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Dumsil Med S.r.l.